ELANE and neoplasm: The work in this study suggests that it may be possible to use proteomic measurements from bulk samples to assess the degree of myeloid infiltration in a tumor, through either the detection of neutrophil granule proteases (e.g., ELANE–PRTN3) directly or the detection of nontryptic peptides generated by these active myeloid serine proteases.